Differential endothelin receptor expression and function in rat myometrial cells and leiomyoma ELT3 cells

Endocrinology

Volumn 150, Issue 10, 2009, Pages 4766-4776

  Raymond, Marie Noëlle ^a   Robin, Philippe ^a   De Zen, Federica ^a   Vilain, Ginette ^a   Tanfin, Zahra ^a  

^a INSTITUTE FOR INTEGRATIVE BIOLOGY OF THE CELL I2BC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; HETERODIMER; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C; SARAFOTOXIN S6C; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; UTERUS MYOMA;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA; ENDOTHELIN-1; ENDOTHELIN-3; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; IODINE RADIOISOTOPES; LEIOMYOMA; MYOMETRIUM; RATS; RATS, LONG-EVANS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; TYPE C PHOSPHOLIPASES; UTERINE NEOPLASMS;

EID: 70349334297     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0118     Document Type: Article

References (57)

1. Davenport AP 2002 International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 54: 219-226
2. Rubanyi GM, Polokoff MA 1994 Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415
3. Levin ER 1995 Endothelins. N Engl J Med 333:356-363
4. Pla P, Larue L 2003 Involvement of endothelin receptors in normal and pathological development of neural crest cells. Int J Dev Biol 47:315-325 (Pubitemid 36975690)
5. Cameron IT, Bacon CR, Collett GP, Davenport AP 1995 Endothelin expression in the uterus. J Steroid Biochem Mol Biol 53:209-214
6. Bacon CR, Morrison JJ, O'Reilly G, Cameron IT, Davenport AP 1995 ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242. J Endocrinol 144:127-134
7. Héluy V, Germain G, Fournier T, Ferré F, Breuiller-Fouché M 1995 Endothelin ETA receptors mediate human uterine smooth muscle contraction. Eur J Pharmacol 285:89-94
8. Khac LD, Naze S, Harbon S 1994 Endothelin receptor type A signals both the accumulation of inositol phosphates and the inhibition of cyclic AMP generation in rat myometrium: stimulation and desensitization. Mol Pharmacol 46:485-494 (Pubitemid 24296682)
9. Robin P, Boulven I, Desmyter C, Harbon S, Leiber D 2002 ET-1 stimulates ERK signaling pathway through sequential activation of PKC and Src in rat myometrial cells. Am J Physiol Cell Physiol 283: C251-C260 (Pubitemid 34670569)
10. Bagnato A, Rosanò L 2008 The endothelin axis in cancer. Int J Biochem Cell Biol 40:1443-1451
11. Nelson J, Bagnato A, Battistini B, Nisen P 2003 The endothelin axis: emerging role in cancer. Nat Rev Cancer 3:110-116 (Pubitemid 37328878)
12. Smollich M, Wülfing P 2007 The endothelin axis: a novel target for pharmacotherapy of female malignancies. Curr Vasc Pharmacol 5:239-248
13. Carducci MA, JimenoA2006 Targeting bone metastasis in prostate cancer with endothelin receptor antagonists. Clin Cancer Res 12: 6296s-6300s
14. Sozen I, Arici A 2002 Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril 78:1-12 (Pubitemid 34722662)
15. Maruo T, Ohara N, Wang J, Matsuo H 2004 Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 10:207-220 (Pubitemid 38750141)
16. Walker CL 2002 Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma. Recent Prog Horm Res 57:277-294
17. Nierth-Simpson EN, Martin MM, Chiang TC, Melnik LI, Rhodes LV, Muir SE, Burow ME, McLachlan JA 2009 Human uterine smooth muscle and leiomyoma cells differ in their rapid 17β-estradiol signaling: implications for proliferation. Endocrinology 150: 2436-2445
18. Breuiller-Fouché M, Honoré JC, Robert B, Fournier T, Vacher-Lavenu MC, Chapron C, Dubuisson JB, Ferré F 1999 [Endothelin receptors in benign human tumours of uterine muscle]. Bull Cancer 86:773-778
19. Pekonen F, Nyman T, Rutanen EM 1994 Differential expression of mRNAs for endothelin-related proteins in human endometrium, myometrium and leiomyoma. Mol Cell Endocrinol 103:165-170 (Pubitemid 24195560)
20. Honoré JC, Robert B, Vacher-Lavenu MC, Chapron C, Breuiller-Fouché M, Ferré F 2000 Expression of endothelin receptors in human myometrium during pregnancy and in uterine leiomyomas. J Cardiovasc Pharmacol 36:S386-S389 (Pubitemid 30815526)
21. Weston G, Trajstman AC, Gargett CE, Manuelpillai U, Vollenhoven BJ, Rogers PA 2003 Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol Hum Reprod 9:541-549 (Pubitemid 37220813)
22. Cesen-Cummings K, Houston KD, Copland JA, Moorman VJ, Walker CL, Davis BJ 2003 Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling. J Soc Gynecol Investig 10:11-20 (Pubitemid 36051093)
23. Hunter DS, Klotzbücher M, Kugoh H, Cai SL, Mullen JP, Manfioletti G, Fuhrman U, Walker CL 2002 Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function. Cancer Res 62:3766-3772 (Pubitemid 34728859)
24. Wei J, Chiriboga L, Mizuguchi M, Yee H, Mittal K 2005 Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata. Mod Pathol 18:179-188 (Pubitemid 40188624)
25. Wei JJ, Chiriboga L, Mittal K 2005 Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata. Fertil Steril 84:474-484 (Pubitemid 41125273)
26. Howe SR, Gottardis MM, Everitt JI, Goldsworthy TL, Wolf DC, Walker C 1995 Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol 146:1568-1579
27. Robin P, Chouayekh S, Bole-Feysot C, Leiber D, Tanfin Z 2005 Contribution of phospholipase D in endothelin-1-mediated extracellular signal-regulated kinase activation and proliferation in rat uterine leiomyoma cells. Biol Reprod 72:69-77 (Pubitemid 40013755)
28. Raymond MN, Bole-Feysot C, Banno Y, Tanfin Z, Robin P 2006 Endothelin-1 inhibits apoptosis through a sphingosine kinase 1-dependent mechanism in uterine leiomyoma ELT3 cells. Endocrinology 147:5873-5882 (Pubitemid 44833504)
29. Boulven I, Palmier B, Robin P, Vacher M, Harbon S, Leiber D 2001 Platelet-derived growth factor stimulates phospholipase C-γ1, extracellular signal-regulated kinase, and arachidonic acid release in rat myometrial cells: contribution to cyclic 3′,5′-adenosine monophosphate production and effect on cell proliferation. Biol Reprod 65:496-506 (Pubitemid 32702314)
30. Williams Jr DL, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV 1991 Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175: 556-561
31. Aramori I, Nirei H, Shoubo M, Sogabe K, Nakamura K, Kojo H, Notsu Y, Ono T, Nakanishi S 1993 Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells. Mol Pharmacol 43:127-131 (Pubitemid 23055054)
32. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M, Yano M 1994 Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91: 4892-4896 (Pubitemid 24177756)
33. Allen BG, Phuong LL, Farhat H, Chevalier D 2003 Both endothelin-A and endothelin-B receptors are present on adult rat cardiac ventricular myocytes. Can J Physiol Pharmacol 81:95-104 (Pubitemid 36398881)
34. Henry PJ, King SH 1999 Typical endothelin ETA receptors mediate atypical endothelin-1-induced contractions in sheep isolated tracheal smooth muscle. J Pharmacol Exp Ther 289:1385-1390
35. Wu-Wong JR, Chiou WJ, Dixon DB, Opgenorth TJ 1995 Dissociation characteristics of endothelin ETA receptor agonists and antagonists. J Cardiovasc Pharmacol 26(Suppl 3):S380-S384
36. Wu-Wong JR, Chiou WJ, Magnuson SR, Opgenorth TJ 1994 Endothelin receptor agonists and antagonists exhibit different dissociation characteristics. Biochim Biophys Acta 1224:288-294
37. Héluy V, Breuiller-Fouché M, Cavaillé F, Fournier T, Ferré F 1995 Characterization of type A endothelin receptors in cultured human myometrial cells. Am J Physiol 268:E825-E831
38. Fomin VP, Cox BE, Word RA 1999 Effect of progesterone on intracellular Ca2+ homeostasis in human myometrial smooth muscle cells. Am J Physiol 276:C379-C385
39. Isaka M, Takaoka K, Yamada Y, Abe Y, Kitazawa T, Taneike T 2000 Characterization of functional endothelin receptors in the porcine myometrium. Peptides 21:543-551 (Pubitemid 30261572)
40. Blomstrand F, Giaume C, Hansson E, Rönnback L 1999 Distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca(2+) signaling. Am J Physiol 277:C616-C627
41. Hasselblatt M, Kamrowski-Kruck H, Jensen N, Schilling L, Kratzin H, Sirén AL, Ehrenreich H 1998 ETA and ETB receptor antagonists synergistically increase extracellular endothelin-1 levels in primary rat astrocyte cultures. Brain Res 785:253-261 (Pubitemid 28179388)
42. Ehrenreich H 1999 The astrocytic endothelin system: toward solving a mystery focus on "distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca(2+) signaling." Am J Physiol 277:C614-C615
43. Harada N, Himeno A, Shigematsu K, Sumikawa K, Niwa M 2002 Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer. Cell Mol Neurobiol 22:207-226
44. Evans NJ, Walker JW 2008 Sustained Ca2+ signaling and delayed internalization associated with endothelin receptor heterodimers linked through a PDZ finger. Can J Physiol Pharmacol 86:526-535
45. Evans NJ, Walker JW 2008 Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophys J 95:483-492
46. Gregan B, Jürgensen J, Papsdorf G, Furkert J, Schaefer M, Beyermann M, Rosenthal W, Oksche A 2004 Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem 279:27679-27687 (Pubitemid 38812609)
47. George SR, O'Dowd BF 2007 A novel dopamine receptor signaling unit in brain: heterooligomers of D1 and D2 dopamine receptors. Scientific World Journal 7:58-63
48. Rauh A, Windischhofer W, Kovacevic A, DeVaney T, Huber E, Semlitsch M, Leis HJ, Sattler W, Malle E 2008 Endothelin (ET)-1 and ET-3 promote expression of c-fos and c-jun in human choriocarcinoma via ET(B) receptor-mediated G(i)- and G(q)-pathways and MAP kinase activation. Br J Pharmacol 154:13-24 (Pubitemid 351620412)
49. Bagnato A, Rosanò L, Spinella F, Di Castro V, Tecce R, Natali PG 2004 Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res 64:1436-1443 (Pubitemid 38235614)
50. Lahav R, Heffner G, Patterson PH 1999 An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo. Proc Natl Acad Sci USA 96:11496-11500 (Pubitemid 29487409)
51. Lahav R, Suvà ML, Rimoldi D, Patterson PH, Stamenkovic I 2004 Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas. Cancer Res 64:8945-8953 (Pubitemid 39665502)
52. Spinella F, Rosanò L, Di Castro V, Decandia S, Nicotra MR, Natali PG, Bagnato A 2007 Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1α in human melanoma cells. Cancer Res 67:1725-1734 (Pubitemid 46383399)
53. Anguelova E, Beuvon F, Leonard N, Chaverot N, Varlet P, Couraud PO, Daumas-Duport C, Cazaubon S 2005 Functional endothelin ET B receptors are selectively expressed in human oligodendrogliomas. Brain Res Mol Brain Res 137:77-88 (Pubitemid 40798889)
54. Curatolo P, Bombardieri R, Jozwiak S 2008 Tuberous sclerosis. Lancet 372:657-668
55. Goncharova EA, Goncharov DA, Eszterhas A, Hunter DS, Glassberg MK, Yeung RS, Walker CL, Noonan D, Kwiatkowski DJ, Chou MM, Panettieri Jr RA, Krymskaya VP 2002 Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. J Biol Chem 277:30958-30967
56. Finlay GA, Hunter DS, Walker CL, Paulson KE, Fanburg BL 2003 Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expression. Am J Physiol Cell Physiol 285:C409-C418
57. Isobe A, Takeda T, Sakata M, Miyake A, Yamamoto T, Minekawa R, Nishimoto F, Okamoto Y, Walker CL, Kimura T 2008 Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation. Hum Reprod 23:440-446 (Pubitemid 351651231)